Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval

The trials will be conducted at nine locations in the country.

Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.The Drug Controller General of India today gave the go-ahead for the Phase-III trials. The trials will be conducted at nine locations in the country.